07:18 AM EST, 02/18/2025 (MT Newswires) -- Axsome Therapeutics ( AXSM ) reported a Q4 loss Tuesday of $1.54 per diluted share, narrower than a loss of $2.08 a year earlier.

Analysts polled by FactSet expected a loss of $0.99.

Revenue for the quarter ended Dec. 31 was $118.8 million, compared with $71.5 million a year earlier.

Analysts surveyed by FactSet expected $118.1 million.

Shares were up more than 1% in premarket activity.